Pharma D-mand Logo
Pharma D-mand Logo

Showcasing your product or service is one way you can display products for extra promotion. Showcasing is like your shop window to generate demand

Case Study

Pharma D-mand case studies will be service providers who have focussed on specific issues and provide insights and how a particular technology or development is useful within the industry.

 

A few things to expect:

 

1. Showcase the real value of a product/service.
2. Build trust.
3. Brand credibility
4. Targeted Demand generation

 

Pharma case studies focus on specific issues and provide insights on how a particular technology or development is useful to the pharma companies. This section presents case studies on industry developments, technologies, products and services.

 

Case studies are a valuable tool for companies looking to generate leads and drive sales. They provide a way to showcase the real-life impact and value of a product or service, and can be used to build trust, credibility, and establish thought leadership in an industry.

GMP Manufacturing

Proven experience in delivering GMP grade products from a wide variety of cell types isolated from various different starting materials, with manufacturing processes which are fully customizable and scalable to support your needs.

Read More >>

CELLSHIP® - An Innovative Xeno-Free Cell Transportation Medium

Life Science Productions fully defined product CellShip®, Xeno-free cell transportation medium. It’s our new alternative to cryopreservation.

Read More >>

Pharma D-mand Logo

Privacy Policy

Dr. Greg Moakes, PHD, Executive Vice President, Business Development

Greg Moakes is Executive Vice President of Business Development for LTS Lohmann Device Technologies LTD. Greg holds a Ph.D. In Chemistry from the Georgia Institute of Technology and an MBA from Southern Methodist University. His career had been focused on drug delivery, first specializing in solid implant dosage formulations and more recently high volume subcutaneous delivery via On-body Delivery Systems.

Dr Kristian Le Vay, Expert Scientist at Coriolis Pharma

Kristian Le Vay is an Expert Scientist at Coriolis, with a focus on novel methods for the developability assessment for biologics. He is a chemist by training with a diverse research background, encompassing the biophysical characterization of complex biomolecules, and the development of advanced therapeutics and drug delivery vectors. He completed his PhD at the Bristol Centre for Functional Nanomaterials (BCFN), University of Bristol, UK, where he developed a keen interest in biophysical method development. Following this, he studied nucleic acid condensation and stability as a postdoctoral scientist at the Max Planck Institute for Biochemistry, Munich, before joining Coriolis in 2022.

Dr. Andrea Hawe, Chief Scientific Officer at Coriolis Pharma

Andrea Hawe is the Chief Scientific Officer at Coriolis. She is an expert in drug product development for biologics with a strong scientific background in protein formulation, surfactant and particle characterization, and lyophilization process technology. Andrea has published more than 40 peer-reviewed papers and book chapters.

Andrea is a pharmacist with a PhD in Pharmaceutical Technology from the LMU Munich. After her PhD, she continued her career as a postdoctoral scientist at the Leiden Academic Center for Drug Research (LACDR) in Leiden (The Netherlands). She was awarded a Veni Fellowship (NWO, The Netherlands) to develop novel approaches for aggregate analysis. She joined Coriolis from the very beginning as a member of the founding team and has been supporting the company since 2008.